5391 - 5400 of 6422 Results
Title
Year
-
OPENTitle: Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's diseaseJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 43Issue #: 7Start Page: 604End Page: 620Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nan.12402Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5632188Citation Count: 60
-
OPENTitle: MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson’s HLA locus exhibits epigenetic regulationJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-025-95679-3Best OA location URL: https://www.nature.com/articles/s41598-025-95679-3.pdfCitation Count: 0
-
OPENTitle: Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 5Start Page: 1501End Page: 1516Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awy072Best OA location URL: https://academic.oup.com/brain/article-pdf/141/5/1501/25901401/awy072.pdfCitation Count: 191
- Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease2020OPENTitle: Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 851End Page: 858Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27993Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27993Citation Count: 38
-
OPENTitle: Mapping of a N-terminal α-helix domain required for human PINK1 stabilization, Serine228 autophosphorylation and activation in cellsJournal Name: Open BiologyPublisher: The Royal SocietyVol: 12Issue #: 1Start Page: 210264End Page: 210264Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1098/rsob.210264Best OA location URL: https://doi.org/10.1098/rsob.210264Citation Count: 38
-
OPENTitle: Group patient visits for Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 18Start Page: 1542End Page: 1547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182194badBest OA location URL: https://n.neurology.org/content/neurology/76/18/1542.full.pdfCitation Count: 22
-
OPENTitle: Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trialJournal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/1745-6215-15-465Best OA location URL: https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/1745-6215-15-465Citation Count: 25
-
OPENTitle: LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 12Issue #: 540Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aav0820Citation Count: 114
-
OPENTitle: Post‐Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 DeliveryJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 9Start Page: 1728End Page: 1736Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29518Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29518Citation Count: 15
-
OPENTitle: High‐molecular‐weight oligomer tau ( HMWoTau ) species are dramatically increased in Braak‐stage dependent manner in the frontal lobe of human brains, demonstrated by a novel oligomer Tau ELISA with a mouse monoclonal antibody ( APNmAb005 )Journal Name: The FASEB JournalPublisher: WileyVol: 38Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1096/fj.202401704rBest OA location URL: https://doi.org/10.1096/fj.202401704rCitation Count: 3